Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007-2012
- PMID: 25375072
- PMCID: PMC5779486
Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007-2012
Abstract
Background: Cervical cancer screening is one of the greatest cancer prevention achievements, yet some women still develop or die from this disease.
Objective: To assess recent trends in cervical cancer incidence and mortality, current screening percentages, and factors associated with higher incidence and death rates and inadequate screening.
Methods: Percentages of women who had not been screened for cervical cancer in the past 5 years were estimated using data from the 2012 Behavioral Risk Factor Surveillance System survey. State-specific cervical cancer incidence data from the United States Cancer Statistics and mortality data from the National Vital Statistics System were used to calculate incidence and death rates for 2011 by state. Incidence and death rates and annual percentage changes from 2007 to 2011 were calculated by state and U.S. Census region.
Results: In 2012, the percentage of women who had not been screened for cervical cancer in the past 5 years was estimated to be 11.4%; the percentage was larger for women without health insurance (23.1%) and for those without a regular health care provider (25.5%). From 2007 to 2011, the cervical cancer incidence rate decreased by 1.9% per year while the death rate remained stable. The South had the highest incidence rate (8.5 per 100,000), death rate (2.7 per 100,000), and percentage of women who had not been screened in the past 5 years (12.3%).
Conclusions: Trends in cervical cancer incidence rates have decreased slightly while death rates have been stable over the last 5 years. The proportion of inadequately screened women is higher among older women, Asians/Pacific Islanders, and American Indians/Alaska Natives.
Implications for public health practice: There continue to be women who are not screened as recommended, and women who die from this preventable cancer. Evidence-based public health approaches are available to increase women's access to screening and timely follow-up of abnormal results.
Figures
Similar articles
-
Trends in cervical cancer incidence and mortality in Oklahoma and the United States, 1999-2013.Cancer Epidemiol. 2018 Oct;56:140-145. doi: 10.1016/j.canep.2018.08.008. Epub 2018 Sep 1. Cancer Epidemiol. 2018. PMID: 30176544 Free PMC article.
-
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.MMWR Suppl. 2014 Oct 31;63(4):3-27. MMWR Suppl. 2014. PMID: 25356673
-
Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.Cancer. 2017 May 15;123(6):1044-1050. doi: 10.1002/cncr.30507. Epub 2017 Jan 23. Cancer. 2017. PMID: 28112816
-
Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)--Behavioral Risk Factor Surveillance System.MMWR CDC Surveill Summ. 1999 Oct 8;48(6):1-22. MMWR CDC Surveill Summ. 1999. PMID: 10526871
-
Implementing recommendations for the early detection of breast and cervical cancer among low-income women.MMWR Recomm Rep. 2000 Mar 31;49(RR-2):37-55. MMWR Recomm Rep. 2000. PMID: 15580731
Cited by
-
Targeting WEE1 Kinase in Gynecological Malignancies.Drug Des Devel Ther. 2024 Jun 20;18:2449-2460. doi: 10.2147/DDDT.S462056. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38915863 Free PMC article. Review.
-
Cervical Cancer Screening Among Female Medicaid Beneficiaries With and Without Schizophrenia.Schizophr Bull. 2024 Jun 6:sbae096. doi: 10.1093/schbul/sbae096. Online ahead of print. Schizophr Bull. 2024. PMID: 38842724
-
Interventions to increase follow-up of abnormal cervical cancer screening results: A systematic literature review and meta-analysis.PLoS One. 2024 Feb 21;19(2):e0291931. doi: 10.1371/journal.pone.0291931. eCollection 2024. PLoS One. 2024. PMID: 38381754 Free PMC article.
-
Sociodemographic characteristics, attitudes, and knowledge associated with previous screening for cervical cancer among women in western Jamaica.Infect Agent Cancer. 2023 Sep 23;18(1):53. doi: 10.1186/s13027-023-00537-4. Infect Agent Cancer. 2023. PMID: 37742036 Free PMC article.
-
The burden of breast, cervical, and colon and rectum cancer in the Balkan countries, 1990-2019 and forecast to 2030.Arch Public Health. 2023 Aug 24;81(1):156. doi: 10.1186/s13690-023-01137-9. Arch Public Health. 2023. PMID: 37620889 Free PMC article.
References
-
- Moyer VA. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156:880–91. - PubMed
-
- Howlader N, Noone AM, Krapcho M, et al., editors. SEER cancer statistics review, 1975–2011. Bethesda, MD: National Cancer Institute; 2013. Available at http://seer.cancer.gov/csr/1975_2011.
-
- Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137:516–42. - PubMed
-
- Freeman HP, Wingrove BK. Excess cervical cancer mortality: a marker for low access to health care in poor communities. Rockville, MD: National Cancer Institute, Center to Reduce Cancer Health Disparities; 2005.
-
- Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97:675–83. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
